|Year : 2017 | Volume
| Issue : 14 | Page : 1755-1756
Hidradenocarcinoma of the Dorsum of the Hand
Wan Cheol Ryu1, Yong Hae Lee1, In Chang Koh1, Jang Sihn Sohn2, Se Min Jang2
1 Department of Plastic and Reconstructive Surgery, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea
2 Department of Pathology, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea
|Date of Submission||05-Mar-2017|
|Date of Web Publication||7-Jul-2017|
In Chang Koh
Department of Plastic and Reconstructive Surgery, Konyang University Hospital, Konyang University College of Medicine, 35365, 158 Gwanjeo Dong-Ro, Seo-gu, Daejeon
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Ryu WC, Lee YH, Koh IC, Sohn JS, Jang SM. Hidradenocarcinoma of the Dorsum of the Hand. Chin Med J 2017;130:1755-6
Hidradenocarcinoma originates in the eccrine glands located in sun-exposed areas and accounts for approximately 6% of malignant eccrine tumors and <0.001% of all skin cancers., Hidradenocarcinoma usually presents as a solitary, firm, asymptomatic intradermal nodule measuring 1–5 cm, covered by intact or occasionally ulcerated purple-, pink-, or blue-colored lesions. While hidradenocarcinoma typically grows slowly over many years, it may suddenly undergo a rapid increase in size. The differential diagnosis of hidradenocarcinoma is very challenging because the appearance of the lesion is benign and similar to that of other skin tumors. In this report, we present the case of a patient with hidradenocarcinoma who was treated with wide excision and full-thickness skin grafting.
A 57-year-old male was incidentally found to have a slowly growing and painless mass in the first web space of the dorsum of the left hand. The patient stated that the mass had been present for 10 years, but its size had increased. Tumor resection was performed in a local private clinic approximately 5 years ago. However, the mass recurred. Upon presentation, examination of the mass revealed an ulcerative and fungating mass measuring 1.5 cm × 1.7 cm and nontender to palpation. On physical examination, the patient showed no associated cubital or axillar lymphadenopathy. Chest and abdomen computed tomography (CT) revealed nonspecific findings. Positron emission tomography-CT (PET-CT) revealed no evidence of distant metastasis.
The mass on the dorsum of the left hand was excised widely, with a 1.5-cm safety margin [Figure 1]a. Immediately after resection, the frozen section revealed the presence of a malignant cell close to the surgical margin, about 1 mm away from the deep margin of the tumor. Further excision of the deep margin was recommended. A second frozen section examination was negative for malignancy of the subcutaneous fat and muscle tissue [Figure 1]b. Subsequently, a full-thickness skin graft was used to cover the defect, with W-plasty to prevent web space contracture. The skin graft was harvested from the left groin area (5.0 cm × 4.5 cm) and fixed at the recipient site. The patient was discharged 5 days after operation and returned to the clinic 4 days later for follow-up. The skin grafts were found to be successful, and the patient's postoperative course was uneventful [Figure 1]c.
|Figure 1: Clinical photographs and pathology findings in a 57-year-old male with hidradenocarcinoma on the dorsum of the hand. (a) The safety margin of 1.5 cm was extended because frozen section examination revealed the presence of a malignant cell close to the surgical margin. (b) The specimen was marked with stitches (one stitch for the proximal part, two stitches for the radial part). (c) Successful skin graft noted at day 5 after operation. (d) Microscopically, the tumor showed irregular-shaped and various-sized solid sheets and nests with invasive growth (original magnification, ×40). (e) Basaloid cell component showing peripheral palisading with a whorl-like arrangement (original magnification, ×400). (f) On immunohistochemical staining, p53 expression significantly increasing (original magnification, ×200).|
Click here to view
Microscopically, the tumor was composed of irregular-shaped solid sheets and infiltrative clusters that varied in size. The tumor surface was ulcerated, with multifocal ischemic necrosis. The depth of invasion was about 0.8 cm from the skin surface, reaching the subcutis tissue. Approximately half of the tumor cells showed abundant pale or clear cytoplasm and distinct cell membranes [Figure 1]d. Mild nuclear pleomorphism with vesicular chromatin distribution and prominent nucleoli was seen. The remaining tumor cells had a basaloid appearance, with scanty eosinophilic cytoplasm, and were arranged in closely packed, patternless nests and whorls [Figure 1]e. Small, round ductal structures and intracytoplasmic vacuoles, suggesting ductal differentiation, were occasionally identified. Perineural invasion was rarely seen, and definite lymphovascular tumor emboli were not identified. On immunohistochemical staining, the tumor cells appeared diffusely reactive for p63, CK5/6, and the epithelial membrane antigen. In addition, p53 expression was significantly increased, and the Ki-67 labeling index was estimated at 70% [Figure 1]f. The overall findings suggested the diagnosis of hidradenocarcinoma. Close observation is ongoing with CT and PET-CT planned for the 6-month follow-up.
Hidradenocarcinoma presents as a combination of histological variants and typically occurs in sun-exposed areas such as the head and neck. Recent reports described occurrences at various sites including the finger, eyelid, scalp, lip, neck, chest wall, breast, back, leg, toe, and perianal area., When tumors occur on the hand, they locate on the palmar area, in correlation with the main distribution of the sweat glands. The dorsum of the hand is not expected to be a site for tumors of the sweat glands due to few sweat glands. Nevertheless, in our patient, hidradenocarcinoma occurred on the dorsum of the hand.
Hidradenocarcinomas have a much higher rate of both local recurrence (14–20%) and lymphatic metastasis (20–24%). Hidradenocarcinomas are treated through surgical excision with sentinel lymph node biopsy, followed by chemotherapeutic protocols mirroring those used for breast cancer, as needed. However, radiation therapy is not recommended in the treatment guidelines for hidradenocarcinoma currently, our patient did not receive chemotherapy, especially since PET-CT revealed no evidence of distant metastasis. Further study is needed to develop a suitable classification system as well as treatment protocols.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Keasbey LE, Hadley GG. Clearcell hidradenoma; report of three cases with widespread metastases. Cancer 1954;7:934-52. doi: 10.1002/1097-0142(195409)7:5<934::AID-CNCR2820070519>3.0. CO;2-5.
Souvatzidis P, Sbano P, Mandato F, Fimiani M, Castelli A. Malignant nodular hidradenoma of the skin: Report of seven cases. J Eur Acad Dermatol Venereol 2008;22:549-54. doi: 10.1111/j.1468-3083.2007.02504.x.
Singh G, Narasimha A, Kumar H, Datti N. Clear cell hidradenocarcinoma of the eyelid: A case report with a review of the literature. Int Ophthalmol 2013;33:171-5. doi: 10.1007/s10792-012-9645-y.
Singh R, Brewer J, Bernstein ZP, Higgs D. No sweat, a rare case of hidradenocarcinoma. Am Surg 2012;78:92-3.
Amel T, Olfa G, Faten H, Makrem H, Slim BA, Moncef M. Metastatic hidradenocarcinoma: Surgery and chemotherapy. N Am J Med Sci 2009;1:372-4.